Insider Trading & Ownership - BIOS Incysus Co-Invest I LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BIOS Incysus Co-Invest I LP
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2022-12-12
Purchase		2022-12-13
07:00 am		IN8BIO INC.INABFletcher Aaron G.L.
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
BIOS Incysus Co-Invest I LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
BIOS Capital Management LP
BIOS Advisors GP LLC
Director
10% Owner		75,001$2.4788$185,9124,270,424
(Indirect)		View
2022-09-28
Purchase		2022-09-29
06:14 am		IN8BIO INC.INABFletcher Aaron G.L.
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
BIOS Incysus Co-Invest I LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
BIOS Capital Management LP
BIOS Advisors GP LLC
Director
10% Owner		25,000$2.0214$50,5354,261,689
(Indirect)		View
2022-08-26
Purchase		2022-08-30
1:16 pm		IN8BIO INC.INABFletcher Aaron G.L.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner		51,214$2.0178$103,3404,258,776
(Indirect)		View
2022-08-26
Purchase		2022-08-30
08:10 am		IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner		51,214$2.0178$103,3404,258,776
(Indirect)		View
2022-08-17
Purchase		2022-08-18
8:00 pm		IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner		50,000$1.93$96,5004,252,810
(Indirect)		View
2022-08-16
Purchase		2022-08-17
10:27 am		IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund III QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner		1,773,684$1.9$3,370,0004,348,150
(Indirect)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-10-04
Disposition		2024-10-11
6:12 pm		2023-12-13
2025-06-13		IN8BIO INC.INABFletcher Aaron G.L.
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
BIOS Incysus Co-Invest I LP
Bios Clinical Opportunity Fund LP
Bios Equity COF LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner		574,241$011,862,579
(Indirect)		View
2024-10-04
Option Award		2024-10-11
6:12 pm		2023-12-13
2025-10-04		IN8BIO INC.INABFletcher Aaron G.L.
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
BIOS Incysus Co-Invest I LP
Bios Clinical Opportunity Fund LP
Bios Equity COF LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner		574,241$011,862,579
(Indirect)		View
2021-08-03
Conversion		2021-08-03
4:57 pm		N/A
N/A		IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
10% Owner		12,649,578$0359,374
(Indirect)		View

Ownership		2021-07-29
9:36 pm		N/A
N/A		IN8BIO INC.INABKreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
10% Owner		0$06,625,102
(Indirect)		View